Maravai Lifesciences Holdings (MRVI) Short-term Investments (2024)

Maravai Lifesciences Holdings (MRVI) recorded quarterly Short-term Investments of $1.4 million in Q4 2024, down 79.09% quarter-over-quarter from $6.6 million in Q2 2024.

Maravai Lifesciences Holdings (MRVI) Short-term Investments (2024) Analysis & Trends

Maravai Lifesciences Holdings' Short-term Investments history runs 1 years deep, the most recent figure standing at $1.4 million for Q4 2024.

  • In Q4 2024, Short-term Investments changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2024 stood at $1.4 million (changed N/A YoY), while the FY2024 annual figure was $1.4 million, changed N/A from the prior year.
  • Short-term Investments was $1.4 million for Q4 2024 at Maravai Lifesciences Holdings, down from $6.6 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $6.6 million in Q2 2024 to a low of $1.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Maravai Lifesciences Holdings 747.50 Mn 739.10 Mn 33.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 1.38 Mn
Jun 30, 2024 6.58 Mn